title: Endogenous cholinergic inputs and local circuit mechanisms govern the phasic mesolimbic dopamine response to nicotine.
abstract: Nicotine exerts its reinforcing action by stimulating nicotinic acetylcholine receptors (nAChRs) and boosting dopamine (DA) output from the ventral tegmental area (VTA). Recent data have led to a debate about the principal pathway of nicotine action: direct stimulation of the DAergic cells through nAChR activation, or disinhibition mediated through desensitization of nAChRs on GABAergic interneurons. We use a computational model of the VTA circuitry and nAChR function to shed light on this issue. Our model illustrates that the α4β2-containing nAChRs either on DA or GABA cells can mediate the acute effects of nicotine. We account for in vitro as well as in vivo data, and predict the conditions necessary for either direct stimulation or disinhibition to be at the origin of DA activity increases. We propose key experiments to disentangle the contribution of both mechanisms. We show that the rate of endogenous acetylcholine input crucially determines the evoked DA response for both mechanisms. Together our results delineate the mechanisms by which the VTA mediates the acute rewarding properties of nicotine and suggest an acetylcholine dependence hypothesis for nicotine reinforcement.
authors: Group for Neural Theory, Laboratoire de Neurosciences Cognitives, INSERM Unité 969, Départment d'Etudes Cognitives, École Normale Supérieure, Paris, France. michael.graupner@nyu.edu
authors: Michael
authors: M
authors: Graupner
authors: Reinoud
authors: R
authors: Maex
authors: Boris
authors: B
authors: Gutkin
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D003198:Computer Simulation; D004298:Dopamine; D059290:Dopaminergic Neurons / Q000378:metabolism / Q000502:physiology*; D051379:Mice; D008959:Models, Neurological; D009538:Nicotine / Q000378:metabolism*; D011978:Receptors, Nicotinic / Q000378:metabolism / Q000502:physiology*; D017557:Ventral Tegmental Area / Q000166:cytology / Q000502:physiology
chemical_list: D011978:Receptors, Nicotinic; D009538:Nicotine; D000110:Acetylcholinesterase; D000109:Acetylcholine; D004298:Dopamine
references: J Consult Clin Psychol. 1982 Dec;50(6):804-19
references: 7174974
references: J Neurosci. 1998 Oct 1;18(19):8003-15
references: 9742167
references: Neurosci Lett. 1990 Nov 27;120(1):70-3
references: 2293096
references: PLoS Med. 2006 Nov;3(11):e437
references: 17105338
references: J Neurosci. 2007 Aug 1;27(31):8202-18
references: 17670967
references: Nature. 1996 Jul 18;382(6588):255-7
references: 8717040
references: J Neurosci. 2001 Mar 1;21(5):1452-63
references: 11222635
references: J Neurochem. 1997 Jul;69(1):137-43
references: 9202304
references: Brain Res. 1996 Nov 18;740(1-2):151-61
references: 8973809
references: Nat Rev Drug Discov. 2009 Sep;8(9):733-50
references: 19721446
references: J Physiol. 1957 Aug 29;138(1):63-80
references: 13463799
references: Trends Neurosci. 2005 Jul;28(7):371-8
references: 15979501
references: Neuron. 2000 Aug;27(2):349-57
references: 10985354
references: J Neurosci. 2003 Aug 27;23(21):7820-9
references: 12944511
references: Nature. 1997 Nov 27;390(6658):401-4
references: 9389479
references: Neuron. 2009 Mar 12;61(5):786-800
references: 19285474
references: Eur J Neurosci. 1993 Feb 1;5(2):137-44
references: 8261095
references: J Physiol. 2010 May 1;588(Pt 9):1395-7
references: 20436045
references: Prog Neurobiol. 2008 Apr;84(4):329-42
references: 18242816
references: Neuroscience. 1993 Dec;57(4):1047-60
references: 7508582
references: Synapse. 2002 Mar 15;43(4):227-37
references: 11835517
references: Mol Pharmacol. 1994 Feb;45(2):212-20
references: 7509438
references: J Neurosci. 2003 Apr 15;23(8):3176-85
references: 12716925
references: J Neurosci. 2000 May 15;20(10):3864-73
references: 10804226
references: J Neurosci. 1989 Apr;9(4):1233-41
references: 2703874
references: Nat Rev Neurosci. 2010 Jun;11(6):389-401
references: 20485364
references: J Neurosci. 1995 Sep;15(9):5859-69
references: 7666171
references: Neuron. 2002 Mar 14;33(6):905-19
references: 11906697
references: J Comp Neurol. 1999 Jul 26;410(2):197-210
references: 10414527
references: J Neurosci. 2001 Mar 15;21(6):1819-29
references: 11245666
references: Eur J Pharmacol. 2000 Mar 30;393(1-3):295-314
references: 10771025
references: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
references: 2899326
references: J Pharmacol Exp Ther. 1997 Jan;280(1):346-56
references: 8996215
references: Science. 2004 Nov 5;306(5698):1029-32
references: 15528443
references: Acta Pharmacol Sin. 2009 Jun;30(6):681-93
references: 19498415
references: Mol Pharmacol. 1994 Mar;45(3):546-54
references: 8145738
references: Drug Alcohol Depend. 1993 Jun;33(1):23-9
references: 8370337
references: Neuron. 1996 May;16(5):905-8
references: 8630247
references: Neural Netw. 2002 Jun-Jul;15(4-6):507-21
references: 12371508
references: J Neurophysiol. 2004 Jan;91(1):346-57
references: 13679411
references: J Physiol. 2003 Dec 15;553(Pt 3):857-71
references: 14555718
references: Acta Physiol Scand. 1988 Dec;134(4):567-8
references: 3250223
references: Synapse. 1996 Mar;22(3):195-208
references: 9132987
references: Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5190-5
references: 20212132
references: Curr Top Med Chem. 2004;4(3):283-97
references: 14754448
references: Neuropsychopharmacology. 2011 Oct;36(11):2244-57
references: 21716264
references: Eur J Pharmacol. 1999 Jun 30;375(1-3):13-30
references: 10443561
references: Neuron. 2001 Aug 16;31(3):349-52
references: 11516393
references: Proc Natl Acad Sci U S A. 2011 May 3;108(18):7577-82
references: 21502501
references: Biophys J. 1972 Jan;12(1):1-24
references: 4332108
references: Brain Res. 1985 Apr 29;333(1):169-72
references: 2859910
references: J Comp Neurol. 1992 Jun 8;320(2):145-60
references: 1377716
references: Psychopharmacology (Berl). 1997 Mar;130(2):85-90
references: 9106904
references: J Neurosci. 2004 Dec 15;24(50):11244-52
references: 15601930
references: Neuron. 2005 May 19;46(4):681-92
references: 15944135
references: J Neurosci. 1989 Oct;9(10):3463-81
references: 2795134
references: Science. 1997 Oct 3;278(5335):58-63
references: 9311927
references: Mol Pharmacol. 1995 Oct;48(4):774-82
references: 7476906
references: Neuropharmacology. 2010 Jun;58(7):1054-66
references: 20114055
references: Mol Psychiatry. 2013 Mar;18(3):382-93
references: 22751493
references: Science. 1984 Sep 21;225(4668):1335-45
references: 6382611
references: Nature. 1998 Jan 8;391(6663):173-7
references: 9428762
references: Eur J Neurosci. 2000 Oct;12(10):3596-604
references: 11029630
references: Brain Res Bull. 1990 Aug;25(2):271-84
references: 1699638
references: Curr Opin Neurobiol. 2008 Apr;18(2):185-96
references: 18708140
references: J Physiol. 1992 May;450:455-68
references: 1331427
references: J Neurosci. 2010 Oct 13;30(41):13814-25
references: 20943922
references: Brain Res Brain Res Rev. 1998 May;26(2-3):198-216
references: 9651527
references: Brain Res. 1994 Aug 8;653(1-2):278-84
references: 7982062
references: Neuron. 2006 Jun 15;50(6):911-21
references: 16772172
references: Life Sci. 2006 May 8;78(24):2812-9
references: 16343553
references: Mol Pharmacol. 2003 Dec;64(6):1283-94
references: 14645658
references: Ann N Y Acad Sci. 2003 Nov;1003:185-95
references: 14684446
references: J Neurosci. 1992 Feb;12(2):483-8
references: 1346804
references: J Neurosci. 1997 Aug 1;17(15):5747-59
references: 9221773